AZTA - Azenta, Inc.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Jupiter Topco LLC bought a new stake in Azenta, Inc. (NASDAQ: AZTA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 17,049 shares of the company's stock, valued at approximately $435,000. Several other institutional investors and hedge funds have also recently bought and
BURLINGTON, Mass., Sept. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan extended in connection with the previously announced sale of B Medical Systems S.
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
BlackRock Inc. bought a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,529,450 shares of the company's stock, valued at approximately $192,152,000. BlackRock Inc. owned about
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
American Capital Management Inc. bought a new stake in Azenta, Inc. (NASDAQ: AZTA) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,061,490 shares of the company's stock, valued at approximately $27,089,000. American Capital Management Inc. owned approximately 2.42% of
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.
AZTA went down for a long time, resulting in a multi-year low in May 2026, but the stock has rallied higher since then. While the stock has doubled in value, there is a chart that suggests to be wary of the rally because it could unwind itself in the near future. The current financial model from AZTA makes a case for being long, but that depends on whether AZTA can hit the targets laid out.
Bank of New York Mellon Corp lessened its holdings in shares of Azenta, Inc. (NASDAQ: AZTA) by 26.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 249,272 shares of the company's stock after selling 88,074 shares
Arrowstreet Capital Limited Partnership purchased a new position in Azenta, Inc. (NASDAQ: AZTA) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 71,410 shares of the company's stock, valued at approximately $1,509,000. Arrowstreet Capital Limited Partnership owned
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta NASDAQ: AZTA reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued unevenness in capital equipment markets.
BURLINGTON, Mass., Aug. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2026.
American Capital Management Inc. lifted its holdings in Azenta, Inc. (NASDAQ: AZTA) by 26.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,296,024 shares of the company's stock after buying an additional 274,588 shares during the quarter. Azenta makes up
BURLINGTON, Mass., July 22, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.
BURLINGTON, Mass., July 8, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.